We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

CNS
Poster (digital)
Clinical
Unconventional treatment in GBM with pseudoprogression: low-dose radiotherapy could be an option?
Francesco Beghella Bartoli, Italy
PO-1123
A clinico-dosimetric correlation of lacrimal gland dose and dry eyes in definitive CNS irradiation
MINAKSHI MISHRA, India
PO-1124
Long-term efficacy and toxicity following CyberKnife radiation for Vestibular Schwannoma
Lucy Solway, United Kingdom
PO-1125
Hypofractionated radiotherapy in poor prognosis patients affected by glioblastoma
Alba Fiorentino , Italy
PO-1126
The STEREOBRAIN trial: a case-control study of SRS vs WBRT in 4-10 brain metastases
Maximilian Niyazi, Germany
PO-1127
Radiosurgery with Cyberknife® for arteriovenous malformations: technical and dosimetrical analysis
Esmeralda Scipilliti, Italy
PO-1128
Post-operative Proton Beam Therapy in cervical chordoma
Katarzyna Holub, Spain
PO-1129
Stereotactic Radiosurgery for trigeminal neuralgia using Exactrac Dynamic. First experience
URIEL ALEXANDER CORRO VERDE, Spain
PO-1130
hypofractionated and intesified radiotherapy in glioblastoma multiforme
Íñigo Nieto Regueira, Spain
PO-1131
Clinical outcomes after radiosurgery in vestibular schwannomas
Beatriz Vázquez Barreiro, Spain
PO-1132
Comparative planning study (IMPT vs VMAT) on sparing OARs important for neurocognition in gliomas
Laurien De Roeck, Belgium
PO-1133
Management approaches in Grade III Meningioma and Haemangiopericytoma: a NOTCH national case series
Caroline Dobeson, United Kingdom
PO-1134
The challenge of glioblastoma recurrence treatment: a real-life experience with regorafenib.
Ciro Mazzarella, Italy
PO-1135
Linac-based Radiosurgery and Hypofractionated radiotherapy for the Meingeomas
Ahmed Gawish, Germany
PO-1136
Safety And Efficacy Of Silibinin In Patients With Brain Metastases after Radiosurgery: Sustain Trial
Isacco Desideri, Italy
PO-1137
Stereotactic radiosurgery in the management of vestibular schwannoma:a single-institution experience
Catarina Silva, Portugal
PO-1138
Hypofractionated radiotherapy for glioblastoma: therapeutic outcomes, toxicities and quality of life
Fatma Dhouib, Tunisia
PO-1139
Survival after stereotactic radiosurgery for brain metastases – A single-institution experience
Tine Schytte, Denmark
PO-1140
Stereotactic ablative body radiation therapy for spinal metastases; A single institution study
Meabh McNulty, Ireland
PO-1141
Clinical outcomes following Stereotactic Radiosurgery for Brain Metastases from Ovarian Carcinoma
Guhan Rangaswamy, Ireland
PO-1142
High LRIG1 expression is associated with better prognosis for patients with Glioblastoma Multiforme
Hristina Ivanovska-Peneva, Bulgaria
PO-1143
Determinants of survical on Brazilian pediatric patients with high grade gliomas
Gustavo Marta , Brazil
PO-1144
IORT for Brain Metastases: Final First-Stage Results of a Single-Arm, Open-Label, Phase 2 Trial
Douglas Castro, Brazil
PO-1145
Moderated hypofractionation in brain metastases and cerebral edema
Carmen Corral Fernandez, Spain
PO-1146
Hypofractionated RT for non-elderly patients with malignant gliomas: Institutional experience
Gustavo Ferraris, Argentina
PO-1147
Radiosurgery in brain metastases: prognostic scales
Abrahams Ocanto, Spain
PO-1148
Clinico-pathological and prognostic factors of Medulloblastoma - Tertiary care centre in India
Renu Madan, India
PO-1149
Cost-effectiveness of treatment strategies for spinal metastases
Roman Kowalchuk, USA
PO-1150
Impact of SRS to melanoma brain metastases associated with immunotherapy on OS: real-world evidence
Douglas Castro, Brazil
PO-1151
Prognostic impact of lymphopenia during temozolomide chemoradiation in patients with glioblastoma
Weir Chiang You, Taiwan
PO-1152
Toxicity of hypofractionated radiotherapy and TMZ in elderly patients with glioblastoma
Stephanyie Payano, Spain
PO-1153
Survival evolution of patients with brain metastases treated with radiosurgery along 10 years
Mikel Rico Oses, Spain
PO-1154
Clinical outcome with radiotherapy in management of Craniopharyngioma: A Single institute experience
Subhash Gupta, India
PO-1155
Effectiveness of 6D couch with daily imaging for reducing PTV margins for Glioblastoma Multiforme
Deep Shankar Pruthi, India
PO-1156
Comprehensive comparison of prognostic scores for patients with newly diagnosed brain metastases
Johannes Kraft, Germany
PO-1157
Re-irradiation with Stereotactic Radiotherapy for Recurrent High Grade Glial Tumors
Ela Delikgoz Soykut, Turkey
PO-1158
Stereotactic radiosurgery and combined immunotherapy with ipilimumab and nivolumab for melanoma brain metastases
Raphael Bodensohn, Germany
PO-1159
CHASING A RARITY: A RETROSPECTIVE SINGLE CENTRE EVALUATION OF PROGNOSTIC FACTORS IN GLIOSARCOMA
Muemtaz Koeksal, Germany
PO-1160
Protons in posterior fossa ependymoma- a dosimetric comparison with photons
Durga Harika Kannikanti, United Kingdom
PO-1161
MRI texture analysis of radionecrosis and isodoses levels after radiosurgery in brain metastases
Sandra Fernandez Alonso, Spain
PO-1162
Metaanalysis of fractionation schedules to hypothesize a benefit of dose escalation in glioblastoma
Franziska Eckert, Austria
PO-1163
Prolonged overall survival for IDH negative glioblastomas recurrence with re-irradiation
Véronique Vendrely, France
PO-1164
Pattern of recurrence of glioblastoma treated with non-coplanar volumetric modulated arc therapy
Rafael Moleron, United Kingdom
PO-1165
Impact of radiation techniques on hematological toxicity during craniospinal irradiation
Renu Madan, India
PO-1166
Re-irradiation in glioblastoma: is it possible? Is it feasible?
Alessia Surgo, Italy
PO-1167
Systematic Review and Individual Patient data in Lipoid Neurocytoma - Impact of Radiotherapy
Jhansi Pattanaik, India
PO-1168
IMPACT OF RECURRENCE PATTERN IN PATIENTS UNDERGOING A SECOND SURGERY FOR RECURRENT GLIOBLASTOMA
Noemi Giannini, Italy
PO-1169